Genotyping 2 SNPs in Chinese Breast Cancers
NCT02886845 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000
Last updated 2022-01-14
Summary
The purpose of this study is to determine the frequency of two Single Nucleotide Polymorphisms (SNPs) by sanger-sequencing in Breast Cancers and healthy controls .
Conditions
- rs185670819 and rs183489969
Interventions
- GENETIC
-
rs183489969,rs185670819
compare the frequency of two germline mutations in breast cancers and controls
Sponsors & Collaborators
-
Song Hongping
lead OTHER
Principal Investigators
-
hongping song, PhD · The First Affiliated Hospital of Fourth Military Medical University
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-08-31
- Primary Completion
- 2023-06-30
- Completion
- 2023-06-30
Countries
- China
Study Locations
More Related Trials
-
BRCA1 Haploinsufficiency and Gene Expression
NCT00597987 ·Status: COMPLETED
-
Testing BRCA 1/2 Mutation Using Next Generation Sequencing
NCT02151747 ·Status: COMPLETED
-
Genetic Characteristics of Metastatic Breast Cancer Patients
NCT04258735 ·Status: UNKNOWN ·Phase: NA
-
A Study on Association Between HR Genes and the HRD Status in Chinese Epithelial Ovarian Cancer
NCT04651920 ·Status: COMPLETED
-
ctDNA Screening in Advanced HER2 Positive Gastric Cancer
NCT04520295 ·Status: UNKNOWN
-
Chemotherapy on Methylation Patterns in Breast Tumor Tissue Correlating With Clinical Response and Outcomes
NCT00698477 ·Status: UNKNOWN
-
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
NCT01034033 ·Status: RECRUITING
-
Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom
NCT00757614 ·Status: UNKNOWN
-
DNA in Predicting Response After Systemic Therapy in Women With Metastatic Breast Cancer
NCT00899548 ·Status: COMPLETED
-
A Cohort Study of Hereditary Ovarian Cancer Risk Prediction Models and Pathogenesis Exploration
NCT06564428 ·Status: RECRUITING
-
UGT1A1 Genotyping in Taiwanese Cancer Patients
NCT05792943 ·Status: UNKNOWN
-
Markers for Predicting Risk of Breast Cancer in Women of Different Races
NCT02574546 ·Status: WITHDRAWN
-
Characterisation of Gene Variants in the Angiogenic Pathway
NCT00716287 ·Status: UNKNOWN
-
Establishing the Incidences of BRCA1 and BRCA2 Mutation by Combining DHPLC and Direct Sequencing in Ovarian Cancer
NCT00155896 ·Status: UNKNOWN
-
Clinical Benefit of Genetic Biomarkers for Guiding Treatment Decisions in Oncology Drugs
NCT02458040 ·Status: WITHDRAWN
-
A Qualitative Exploration of the Impact of Positive BRCA1/2 Mutation Status on the Lives of Young Women
NCT00858078 ·Status: COMPLETED
-
Evaluating Microarray Pharmacogenetic Testing in Cancer Patients
NCT06489041 ·Status: RECRUITING ·Phase: NA
-
Prospective Screening for Patient-Specific Genotypes and Phenotypes That Influence Drug Dosing and Trial Selection in Cancer Patients
NCT02706652 ·Status: TERMINATED
-
HER-2 Mutations in Tumor Samples From Patients With Advanced Non-Small Cell Lung Cancer Treated on Clinical Trial ECOG-2598
NCT00896909 ·Status: COMPLETED
-
Discovering New Genetic Markers in Adults and Children Who May Be At Risk for Hereditary Forms of Cancer
NCT03922893 ·Status: RECRUITING
-
Clinical Significance of Germline BRCA Mutations
NCT00579488 ·Status: ACTIVE_NOT_RECRUITING
-
DNA Repair and Genetic Susceptibility to Lung Cancer
NCT00611598 ·Status: COMPLETED
-
Genetic Studies in Liver Cancer Patients
NCT00172640 ·Status: UNKNOWN
-
DNA Analysis of Tissue Samples From Patients With Head and Neck Cancer
NCT00898664 ·Status: COMPLETED
-
International Cancer of the Head and Neck, Genetics and Environment (InterCHANGE) Study
NCT01972802 ·Status: UNKNOWN